Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Myokardia Inc (MYOK)

Myokardia Inc (MYOK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,992,876
  • Shares Outstanding, K 53,323
  • Annual Sales, $ 0 K
  • Annual Income, $ -276,210 K
  • 60-Month Beta 1.84
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 14.11
Trade MYOK with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -5.64
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/09/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -1.41
  • Number of Estimates 4
  • High Estimate -1.10
  • Low Estimate -1.68
  • Prior Year -1.27
  • Growth Rate Est. (year over year) -11.02%

Price Performance

See More
Period Period Low Period High Performance
1-Month
221.90 +1.36%
on 10/20/20
225.00 -0.04%
on 11/16/20
+2.91 (+1.31%)
since 10/16/20
3-Month
97.83 +129.90%
on 08/20/20
225.00 -0.04%
on 11/16/20
+125.67 (+126.63%)
since 08/14/20
52-Week
42.65 +427.34%
on 04/02/20
225.00 -0.04%
on 11/16/20
+169.96 (+309.30%)
since 11/15/19

Most Recent Stories

More News
Novus Therapeutics Appoints June Lee, M.D., to Board of Directors

Novus Therapeutics, Inc. ("Novus") (NASDAQ: NVUS), a clinical stage biopharmaceutical company focused on developing life-changing, targeted medicines for patients undergoing organ or cellular transplantation,...

MYOK : 224.91 (+0.05%)
NVUS : 14.60 (-5.19%)
Bristol Myers Squibb Completes Acquisition of MyoKardia, Strengthening Company's Leading Cardiovascular Franchise

Bristol Myers Squibb (NYSE:BMY) announced today that it has successfully completed its acquisition of MyoKardia, Inc. in an all cash transaction for approximately $13.1 billion. With the completion of...

MYOK : 224.91 (+0.05%)
BMY : 67.34 (-0.07%)
MyoKardia Presents Cardiac Imaging Data from 30-Week EXPLORER-HCM Study of Mavacamten

EXPLORER-HCM Cardiac Imaging Data Presented at AHA 2020 Scientific Session with Simultaneous Publication in Circulation

MYOK : 224.91 (+0.05%)
MyoKardia Presents Mavacamten Clinical and Non-Clinical Data at the American Heart Association's Scientific Sessions 2020

ECHO Data from EXPLORER-HCM Show Mavacamten Treatment Improved Cardiac Structure and Mitral Valve Function in Obstructive Hypertrophic Cardiomyopathy Patients

MYOK : 224.91 (+0.05%)
MyoKardia Collaborates with the American College of Cardiology and PINNACLE/Veradigm to Launch Patient Registry of Hypertrophic Cardiomyopathy

MyoKardia, Inc. (NASDAQ: MYOK), and the American College of Cardiology (ACC) announced the establishment of a nationwide registry of hypertrophic cardiomyopathy (HCM), which leverages the ACC's PINNACLE...

MYOK : 224.91 (+0.05%)
MDRX : 18.08 (+0.17%)
Bristol Myers Squibb Prices $7 Billion of Senior Unsecured Notes

Bristol Myers Squibb (NYSE:BMY) today announced that it has priced a public offering (the "Offering") of senior unsecured notes in a combined aggregate principal amount of $7 billion (collectively, the...

MYOK : 224.91 (+0.05%)
BMY : 67.34 (-0.07%)
Should You Invest in the SPDR SP Pharmaceuticals ETF (XPH)?

Sector ETF report for XPH

XPH : 52.90 (-0.36%)
RPRX : 44.90 (-3.71%)
HZNP : 93.29 (-0.70%)
PJP : 81.55 (-0.65%)
IHE : 187.83 (-0.92%)
MYOK : 224.91 (+0.05%)
MyoKardia Reports Third Quarter 2020 Financial Results

MyoKardia, Inc. (Nasdaq: MYOK) today reported financial results for the third quarter ended September 30, 2020.

BMY : 67.34 (-0.07%)
MYOK : 224.91 (+0.05%)
Bristol-Myers (BMY) Q3 Earnings Beat, '20 EPS View Raised

Bristol-Myers (BMY) beats on earnings and sales in the third quarter on strength of Revlimid and Eliquis.

PFE : 40.15 (-1.30%)
MRK : 76.27 (+0.17%)
BMY : 67.34 (-0.07%)
MYOK : 224.91 (+0.05%)
Bristol Myers Squibb Reports Third Quarter 2020 Financial Results

Bristol Myers Squibb (NYSE:BMY) today reports results for the third quarter of 2020, which reflect strong product sales, continued pipeline advancement and robust operating performance.

BMY : 67.34 (-0.07%)
EXEL : 22.98 (+0.13%)
BLUE : 34.10 (+0.62%)
MYOK : 224.91 (+0.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

MyoKardia, Inc. is a biopharmaceutical company. The company focuses on discovering, developing, and commercializing therapies for the treatment of serious and neglected rare cardiovascular diseases. Its product candidate consists of MYK-461, a small molecule to reduce excessive cardiac muscle contractility...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 225.29
1st Resistance Point 225.10
Last Price 224.91
1st Support Level 224.62
2nd Support Level 224.33
3rd Support Level N/A

See More

52-Week High 225.00
Last Price 224.91
Fibonacci 61.8% 155.34
Fibonacci 50% 133.82
Fibonacci 38.2% 112.31
52-Week Low 42.65

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar